IFNA1 and systemic lupus erythematosus: Similarly, in systemic lupus erythematosus, which is also characterized by a prominent IFN signature, the expression levels of IFN signature genes have been observed to correlate positively with the efficacy of targeted therapies that inhibit the IFN pathway65.